162 results
8-K
EX-99.1
BIOCQ
Biocept Inc
22 Aug 23
Biocept Reports Second Quarter 2023 Financial Results
4:10pm
-of-care guidelines. We believe securing this status will broaden physician adoption and support reimbursement that reflects our test’s value in clinical … of CNSide in clinical care guidelines; Medicare and private payors may not provide coverage and reimbursement or may breach, rescind or modify
424B4
BIOCQ
Biocept Inc
25 May 23
Prospectus supplement with pricing info
5:23pm
and reimbursement of expenses.
We have granted the underwriters an option for a period of 45 days from the date of this prospectus to purchase up … ability to obtain coverage and adequate reimbursement from governmental and other third-party payers for assays and services;
our ability to enter
8-K
EX-99.1
ba513
15 May 23
Biocept Reports First Quarter 2023 Financial Results
6:07am
DEFR14A
yb0ofb
21 Apr 23
Revised proxy
8:30am
8-K
EX-99.1
mnorf44ox h2v1iz63t
17 Apr 23
Biocept Reports 2022 Financial Results
4:46pm
8-K
EX-99.1
9yn fsl8a7u
21 Nov 22
Biocept Reports Third Quarter 2022 Financial Results
4:31pm
8-K
EX-99.1
d3jcu71f
14 Nov 22
Biocept Reports Second Quarter 2022 Financial Results
8:01am